1. European Medicines Agency: Updated review of influenza antiviral medicinal products for potential use during pandemic by the Committee for Medicinal Products for Human Use (CHMP) of the ...

What have been the guiding principles in these achievements and what might the future hold for antiviral drug development? In the late 1970s, the discovery that acyclic nucleoside analogues ...

Our interviewees this month describe the rewards and challenges of their complementary roles in antiviral drug discovery and development. Joseph Vacca, Ph.D. Executive Director, Medicinal ...

However, people with a high risk of flu complications or extremely sick from the flu may need to take antiviral medications.

Antiviral drugs can be used for the treatment of influenza and the prevention of seasonal and post-exposure influenza. Four antiviral drugs are available for the prevention and treatment of ...

Four antiviral drugs are available for the prevention and treatment of influenza infections: oseltamivir, zanamivir, rimantadine and amantadine. Oseltamivir and zanamivir are neuraminidase ...

Pfizer’s Paxlovid and Merck & Co’s Molnupiravir are two oral antiviral treatments authorised for patients with mild to moderate COVID-19 symptoms at a high risk of developing severe illness.

The two strains, I223V and S247N, could evade antiviral drugs, according to a publication in the journal Emerging Infectious Diseases, published by the CDC. At least two cases of the flu mutations ...

Dublin, Nov. 01, 2024 (GLOBE NEWSWIRE) -- The "Antiviral Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.